Influence of lung metastases on outcomes of curative management of peritoneal metastases from colorectal cancer
There has always been a skepticism in the management CRC with PM and extraperitoneal disease, especially pulmonary metastases with curative intent. Our study demonstrates that CRS and HIPEC improves OS in such patients and pulmonary metastases per se do not influence the outcomes of disease. Nevertheless, further prospective and multi centric studies are required to validate these findings.
Authors
- Guillaume Passot
- Vahan Képénékian (ORCID: https://orcid.org/0000-0001-9885-8600)
- Laurent Villeneuve (ORCID: https://orcid.org/0000-0002-8713-7821)
- Olivier Gléhen (ORCID: https://orcid.org/0000-0002-2802-4974)
- Ajinkya Pawar (ORCID: https://orcid.org/0000-0001-6435-9563)
- Gabrielle Drevet (ORCID: https://orcid.org/0000-0003-1174-7655)
- Jean‐Michel Maury (ORCID: https://orcid.org/0000-0002-3494-3678)
- Alhadeedi Omar
- N. Stremler‐Le Bel
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Gujarat Cancer & Research Institute (IN)
- Lyon College (US)
- Hospices Civils de Lyon (FR)
- Hôpital Lyon Sud (FR)
Publication Details
- Journal
- European Journal of Surgical Oncology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1016/j.ejso.2025.109650
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 0.00